FIELD: chemistry.
SUBSTANCE: invention relates to a heterocyclic amide compound of general formula I, where A, B, C, R1-R4, R2’-R4’, RB are defined in the claims, and a pharmaceutically acceptable salt thereof, to a method for production thereof.
EFFECT: invention discloses use of the compound for preparing a preparation for treating diseases associated with STING activity, for preparing an immunological adjuvant and for preparing a preparation for activating STING.
16 cl, 2 dwg, 2 tbl, 26 ex
Formula I
| Title | Year | Author | Number |
|---|---|---|---|
| POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR | 2021 |
|
RU2826488C1 |
| PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND | 2021 |
|
RU2819346C1 |
| BENZOXAZINE-OXAZOLIDINONE COMPOUND DISPLACED BY A NITROGEN-CONTAINING HETEROCYCLE, METHOD OF SYNTHESIS AND APPLICATION THEREOF | 2018 |
|
RU2744784C1 |
| THIENOPYRIMIDINE COMPOUNDS, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2158739C2 |
| 3,4-DIHYDROISOQUINOLINE COMPOUND AND USE THEREOF | 2021 |
|
RU2825312C1 |
| O-AMINOHETEROARYLALKYNYL CONTAINING COMPOUND, METHOD FOR ITS PRODUCTION AND ITS USE | 2018 |
|
RU2797694C2 |
| BICYCLIC COMPOUNDS AS PD1/PD-L1 INTERACTION/ACTIVATION INHIBITORS | 2019 |
|
RU2777980C2 |
| COMPOUND WITH NEUROPROTECTOR ACTION, A METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2802457C1 |
| COMPOUNDS OF THIENYL[3, 2-d]PYRIMIDINE-4-ON, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2012 |
|
RU2624021C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS OF 2-AMINOPYRIMIDINE AND THEIR USE | 2020 |
|
RU2795914C1 |
